These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
496 related articles for article (PubMed ID: 17229184)
1. Diagnosis and treatment of obsessive-compulsive disorder and related disorders. Dell'Osso B; Altamura AC; Mundo E; Marazziti D; Hollander E Int J Clin Pract; 2007 Jan; 61(1):98-104. PubMed ID: 17229184 [TBL] [Abstract][Full Text] [Related]
2. Issues in the pharmacological treatment of obsessive-compulsive disorder. Math SB; Janardhan Reddy YC Int J Clin Pract; 2007 Jul; 61(7):1188-97. PubMed ID: 17511795 [TBL] [Abstract][Full Text] [Related]
3. Combining Drug and Psychological Treatments for Obsessive- Compulsive Disorder: What is the Evidence, When and for Whom. Albert U; Di Salvo G; Solia F; Rosso G; Maina G Curr Med Chem; 2018; 25(41):5632-5646. PubMed ID: 28707590 [TBL] [Abstract][Full Text] [Related]
4. [Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders]. Nakamae T Seishin Shinkeigaku Zasshi; 2011; 113(10):1016-25. PubMed ID: 22187889 [TBL] [Abstract][Full Text] [Related]
5. Transcutaneous electrical acupoint stimulation as an adjunct therapy for obsessive-compulsive disorder: A randomized controlled study. Feng B; Zhang ZJ; Zhu RM; Yuan GZ; Luo LY; McAlonan GM; Xu FZ; Chen J; Liu LY; Lv YY; Wong HK; Zhang Y; Zhu LX J Psychiatr Res; 2016 Sep; 80():30-37. PubMed ID: 27281260 [TBL] [Abstract][Full Text] [Related]
11. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. Simpson HB; Foa EB; Liebowitz MR; Ledley DR; Huppert JD; Cahill S; Vermes D; Schmidt AB; Hembree E; Franklin M; Campeas R; Hahn CG; Petkova E Am J Psychiatry; 2008 May; 165(5):621-30. PubMed ID: 18316422 [TBL] [Abstract][Full Text] [Related]
12. Treatment strategies of obsessive-compulsive disorder and panic disorder/agoraphobia. Marazziti D; Carlini M; Dell'Osso L Curr Top Med Chem; 2012; 12(4):238-53. PubMed ID: 22204483 [TBL] [Abstract][Full Text] [Related]
13. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder. Varigonda AL; Jakubovski E; Bloch MH J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):851-859.e2. PubMed ID: 27663940 [TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders. Denys D Psychiatr Clin North Am; 2006 Jun; 29(2):553-84, xi. PubMed ID: 16650723 [TBL] [Abstract][Full Text] [Related]
16. Increased maintenance of obsessive-compulsive disorder remission after integrated serotonergic treatment and cognitive psychotherapy compared with medication alone. Biondi M; Picardi A Psychother Psychosom; 2005; 74(2):123-8. PubMed ID: 15741763 [TBL] [Abstract][Full Text] [Related]
17. [Evidence-based pharmacotherapy and other somatic treatment approaches for obsessive-compulsive disorder: state of the art]. Kordon A; Zurowski B; Wahl K; Hohagen F Nervenarzt; 2011 Mar; 82(3):319-20, 322-4. PubMed ID: 21340636 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological management of obsessive-compulsive disorder: a review for clinicians. McDonough M; Kennedy N Harv Rev Psychiatry; 2002; 10(3):127-37. PubMed ID: 12023928 [TBL] [Abstract][Full Text] [Related]